Connors Michael H, Ames David, Boundy Karyn, Clarnette Roger, Kurrle Sue, Mander Alastair, Ward John, Woodward Michael, Brodaty Henry
Dementia Collaborative Research Centre, School of Psychiatry, UNSW Australia, Sydney, Australia.
Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia.
J Alzheimers Dis. 2016 Apr 12;52(3):967-74. doi: 10.3233/JAD-150946.
Dementia is a terminal illness. While various baseline characteristics of patients, such as age, sex, and dementia severity, are known to predict mortality, little research has examined how changes in patients' symptoms over time predict survival. There are also limited data on patients seen in memory clinics, as opposed to other health care settings, and whether antipsychotic medications are associated with mortality in dementia once patients' demographic and clinical features are controlled for.
To identify predictors of mortality in patients with dementia.
Of 970 patients recruited from nine memory clinics around Australia, 779 patients had dementia at baseline. Patients completed measures of dementia severity, cognition, functional ability, neuropsychiatric symptoms, caregiver burden, and medication use at baseline and at regular intervals over a three-year period. Mortality data were obtained from state registries eight years after baseline.
Overall, 447 (57.4%) of the patients with dementia died within the eight years. Older age, male sex, more severe dementia and functional impairment at baseline, greater decline in dementia severity and functional impairment over six months, taking a larger number of medications, and use of atypical antipsychotic medication predicted earlier mortality.
The findings confirm that demographic and diagnostic features predict the survival of patients with dementia. Importantly, the findings indicate that changes in dementia severity and functional impairment over time predict mortality independently of baseline levels, and provide further evidence for the higher mortality risk of patients taking antipsychotic medications.
痴呆是一种晚期疾病。虽然已知患者的各种基线特征,如年龄、性别和痴呆严重程度,可预测死亡率,但很少有研究探讨患者症状随时间的变化如何预测生存情况。与其他医疗环境相比,记忆诊所中患者的数据也有限,而且在控制患者的人口统计学和临床特征后,抗精神病药物是否与痴呆患者的死亡率相关。
确定痴呆患者死亡率的预测因素。
在从澳大利亚各地9家记忆诊所招募的970名患者中,779名患者在基线时患有痴呆。患者在基线时以及在三年期间定期完成痴呆严重程度、认知、功能能力、神经精神症状、照顾者负担和药物使用情况的测量。在基线八年后从州登记处获取死亡率数据。
总体而言,447名(57.4%)痴呆患者在八年内死亡。年龄较大、男性、基线时痴呆和功能损害更严重、六个月内痴呆严重程度和功能损害下降幅度更大、服用药物数量较多以及使用非典型抗精神病药物可预测更早死亡。
研究结果证实人口统计学和诊断特征可预测痴呆患者的生存情况。重要的是,研究结果表明,痴呆严重程度和功能损害随时间的变化可独立于基线水平预测死亡率,并为服用抗精神病药物患者更高的死亡风险提供了进一步证据。